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SAPHO syndrome is a rare clinical entity composed of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO). We
describe a case of SAPHO syndrome masquerading as metastatic breast cancer in a patient with localized breast cancer who
presented with cord compression. ,ere was no pathologic evidence of metastatic cancer; however, a bone scan indicated osseous
involvement. After multidisciplinary review of images and with additional findings of pustulosis and acne, a clinical diagnosis of
SAPHO was made.
1. Introduction
SAPHO syndrome is a constellation of multiple symptoms
and signs including synovitis, acne, pustulosis, hyperostosis,
and osteitis. It was first described in 1961 by Windam et al.
[1], and the acronym was first coined in 1987 by Chamot
et al. [2]. It has different names including nonbacterial
osteitis, sternoclavicular hyperostosis, pustulotic arthro-
osteitis, spondyloarthritis hyperostotica pustulopsoriatica,
and chronic recurrent multifocal osteomyelitis [3, 4]. ,e
annual prevalence of SAPHO syndrome is estimated at
1/10,000 in Caucasians [5]. It is a rare clinical entity, and
a high index of suspicion is required to diagnose this disease.
We present a case in which a patient with invasive breast
cancer had a collection of findings including joint pain, acne,
and rash involving palms and soles with imaging showing
osseous lesions at multiple sites and diagnosed with SAPHO
syndrome.
2. Case
A 59-year-old African American lady with a history of newly
diagnosed invasive ductal carcinoma of the breast, stage 1A
(pT1b, N0, M0), estrogen receptor and progesterone re-
ceptor positive, and Her-2 negative status post lumpectomy
and radiotherapy presented to the hospital with complaints
of multiple falls and weakness in both arms and legs and
incontinence of urine. Complete blood count revealed
a neutrophilic leukocytosis of 16.6K/μL (3.8–10.6K/μL),
hemoglobin of 13 g/dL (12.0–15.0 g/dL), and platelet of
357K/μL (150–140K/μL). Complete metabolic profile was
normal. ,e patient underwent magnetic resonance imaging
which showed osseous lesions involving the cervical spine,
thoracic spine, and lumbar spine. Sclerotic lesions were also
observed within the left clavicle, sternum, and left T12
proximal rib. ,e patient underwent X-rays of axial and
appendicular skeleton revealing sclerotic appearance of
anterior L4 and L5. ,ere was also abnormal appearance of
the distal left clavicle, medial right, and left clavicles as well
as the sternum.,ere was no evidence of periostitis. Because
of cord compression, the patient underwent vertebral
laminectomies which came back negative for metastatic
disease and negative for bacteria.,e patient also had a bone
scan that showed increased radiotracer uptake within the
medial left clavicle and manubrium centered upon the left
sternoclavicular joint and bilateral 1st costomanubrial joints
(Figure 1). ,ere was also increased radiotracer uptake with
the cervical spine. ,e patient also gave a history of rash
involving palms and soles (Figures 2 and 3) and facial acne
and was seen by a dermatologist in the past and diagnosed
with palmoplantar pustular dermatosis. Cultures of these
pustules were negative. In light of negative biopsies from
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surgical specimens and given low-stage breast cancer, an
alternative diagnosis for her bone lesions was sought. A
comprehensive joint examwas done to evaluate for any bony
abnormalities. ,ere was full range of motion of spine,
shoulders, elbows, wrists, fingers, hips, knees, and ankles.
,ere was no active swelling, tenderness, soft tissue nodules,
or synovitis at any joint. ,ere was tenderness to palpation
over the sternum and sternoclavicular joints. ,ere was no
malar rash or mouth ulcers, or alopecia.
Plasma cell dyscrasia was ruled out by serum and urine
protein electrophoresis and a normal bone marrow biopsy
and skeletal radiographic survey. Given her joint pain, bone
scan findings, palmoplantar pustulosis, and acne, a diagnosis
of SAPHO syndrome was made. ,e patient was then seen
by a rheumatologist and was started on 40mg of daily
prednisone and later transitioned to adalimumab 40mg
every 14 days. She was started on adjuvant Arimidex for her
breast cancer and continues to follow with both oncology
and rheumatology.
3. Discussion
SAPHO syndrome can present at any age but is most
commonly found in children and young adults, and it has
a self-limiting, relapsing, and remitting course [6, 7]. Di-
agnostic criteria for SAPHO syndrome include a combina-
tion of acne, palmoplantar pustulosis, hyperostosis with
or without dermatosis, and recurrent multifocal chronic
osteomyelitis involving the axial or peripheral skeleton, with
or without dermatosis [5]. Synovitis of the affected joint is
also a common presentation of SAPHO syndrome. Patients
can also present with mono or polyarthritis [8]. Various
skeletal sites are found to be affected in SAPHO syndrome,
including anterior chest wall (65% to 90% of cases), spine
(30% of cases with thoracic spine being the most frequently
affected part of spine), appendicular skeleton including long
bones (5% to 10% of cases), and mandibular area (1% to 10%
of cases) [6, 7, 9]. Dermatological manifestations include
palmoplantar pustulosis and severe acne [8]. Osteoarticular
and dermatological manifestations do not necessarily occur
at the same time as the latency period of more than ten years
has also been documented [10]. Lab findings generally in-
clude moderate leukocytosis, mild anemia, elevated acute
phase reactants, elevated immunoglobulin A, and normal or
elevated complement levels [11].
Pathogenesis of SAPHO syndrome remains unknown.
Multiple mechanisms, including genetic, immunological,
and bacterial causes, are found to play an important role in
the development of the disease. Regarding infectious eti-
ology, Propionibacterium acnes have been isolated in biopsy
specimens of both the bone and synovium [7, 8], but despite
this, antibiotic trials are not found to be effective [7]. ,ree
hypotheses have been proposed by Hellmann and Schwartz
regarding autoimmune response playing an important role
in pathogenesis of SAPHO syndrome, which could be
triggered by a bacterial or viral pathogen [12, 13]. According
Figure 1: Anterior and posterior planar images of a 99mTc MDP bone scan show increased radiotracer uptake within the medial left clavicle
and manubrium centered upon the left sternoclavicular joint and bilateral 1st costomanubrial joints. ,ere is also increased radiotracer
uptake with the cervical spine.
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to molecular mimicry hypothesis, whenever there is a re-
semblance between the fragment of microorganism in the
skin with the bone or joint, the immune system mistakenly
attacks the normal bone or joint causing inflammation of
affected joints [14]. According to the second hypothesis,
whenever a fragment of microorganism couples with an
immunoglobulin, an immune complex is formed which de-
posits in the bone or joint and can activate a complement
cascade, thus causing inflammation [15]. Finally, according to
the third hypothesis, which is an immune barrier breakdown
hypothesis, whenever a skin infection breaks down a barrier
between immune cells and dermatologic tissues, normal
antigens in the skin are exposed to the immune system, which
may trigger an inflammatory reaction [16]. In some studies,
association with seronegative spondyloarthropathies has also
been found [7]. HLA B27 has also been found in 30% of
SAPHO patients [8]. ,e main consideration as to why
a spondyloarthropathy was not likely in our patient was the
absence of several key elements including an antecedent
infection, sacroilitis, or ossification of intervertebral ligaments
on imaging, no history of inflammatory bowel disease,
psoriatic rash or ocular symptoms.
,e relationship between cancer and rheumatologic
conditions is bidirectional, in that some conditions pre-
dispose one to cancer and some cancers may present with
rheumatologic features. ,ere is a known association be-
tween rheumatoid arthritis, lupus, Sjo¨gren’s syndrome,
systemic sclerosis, and hematologic malignancies such as
lymphoma and leukemia [17]. Furthermore, the presence of
dermatomyositis/polymyositis may be a clue for an occult
neoplasm [18]. Conversely, paraneoplastic rheumatic syn-
dromes can develop as a result of an underlying malignancy.
Hypertrophic osteoarthropathy (HOA) is one such process
and has a well-known association with lung cancer. HOA is
caused by abnormal growth of bone and skin in the distal
extremities and classically presents as digital clubbing,
symmetric polyarthritis, and periostitis of long bones [19].
,e etiology is unclear, but believed to be caused by tumor-
derived growth factors such as platelet-derived growth factor
(PDGF) and vascular endothelial growth factor (VEGF)
[20]. Typically, signs and symptoms resolve after treatment
of the underlying disease. ,e absence of clubbing, ten-
derness of long bones, and lack of periosteal reaction on
radiographs made HOA in our patient highly unlikely.
Carcinomatous polyarthritis (CP) is associated with various
solid tumors and can present similar to seronegative
rheumatoid arthritis with symmetric involvement of hands,
wrists with morning stiffness, or as an asymmetric migratory
polyarthritis [21]. ,e classic presentation, however, is ad-
vanced aging, acute onset of symptoms, involvement of
lower extremities, and lack of destructive changes on ra-
diographs [22]. Other types of paraneoplastic rheumatic
conditions include remitting seronegative symmetrical sy-
novitis with pitting edema which is thought to be related to
increased levels of VEGF [23], palmar fibromatosis, and
polyarthritis which causes flexion deformities of the hands in
patients with certain solid tumors [24]. Our patient’s history
and symptomatology was not consistent with any of the
paraneoplastic rheumatoid conditions.
For diagnosis of SAPHO syndrome, whole-body scin-
tigraphy is useful because in addition to increased tracer
uptake in the affected bone, it also reveals clinically silent
lesions. ,e bull’s head sign is the pathognomonic of
SAPHO syndrome which is characterized by manubrium
sterni which represents the upper skull and the inflamed
sternoclavicular joint with the adjacent clavicle representing
the horns [25]. ,ough this sign is pathognomonic for
SAPHO syndrome, it is not sensitive [26]. Plain radiographs,
CTscans, andMRI are also found to be helpful in diagnosing
SAPHO syndrome. Histological characteristics of bone le-
sions involve acute inflammation with predominantly
a neutrophilic infiltrate [8]. ,e differential diagnoses of
SAPHO syndrome include osteosarcoma, infectious osteo-
myelitis, bony metastasis, Ewing’s sarcoma, Paget’s disease,
sternoclavicular osteoarthritis, infectious spondylodiscitis,
and many others [8].
Figure 2: Photograph of the left palm demonstrating healed
pustules. Similar findings were on the right palm.
Figure 3: Photograph of the left sole lesions demonstrating pus-
tulosis. Similar findings were on the right sole.
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Regarding treatment of SAPHO syndrome, nonsteroidal
anti-inflammatory drugs (NSAIDs) are the first line of
agents [6]. But a lot of patients do not get any relief from
NSAIDs alone. Propionibacterium acne, which is found to
play an important role in pathogenesis of SAPHO syndrome,
can be treated with antibiotics that have been found to
decrease the disease activity in one of the studies [27].
Corticosteroids, colchicine, and disease-modifying anti-
rheumatic drugs (DMARDs), including methotrexate and
sulfasalazine, are also found to be effective in some of the
case studies [8]. In patients who are refractory to the
abovementioned treatment, biological agents such as tumor
necrosis factor inhibitors including infliximab, etanercept,
or adalimumab have also been used with varying results [6].
Bisphosphonates which inhibit bone resorption and also
have probable anti-inflammatory properties have also been
used in patients who are refractory to the NSAIDs, corti-
costeroids, colchicine, and DMARDs [6]. Finally, surgical
procedures including partial or complete resection, sau-
cerization, and decortication of the affected bone have also
been shown to be useful in some of the cases [6].
4. Conclusion
,e course of the disease is highly variable, owing to the fact
that not all signs may be present at the same time. Recent
studies show that 13% of patients had monophasic disease,
and 35% of the patients had relapsing and remitting course
[28]. Predictors of chronic disease include female gender,
involvement of anterior chest wall, dermatologic lesions,
peripheral arthritis, and elevated levels of acute phase re-
actants [6]. SAPHO syndrome is a distinct clinical entity
with characteristic dermatologic and osteoarticular abnor-
malities and should be considered in the differential diagnosis
of sclerotic and hyperostotic bone lesions in low-stage cancers
to prevent the use of chemotherapy and radiotherapy in
patients with malignancy [8]. Management of a patient with
SAPHO syndrome is multidisciplinary in nature [1, 29], and
a high index of suspicion is required to diagnose and treat this
condition.
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